Since its inception, SU2C has contributed to numerous breakthroughs in cancer research. Key achievements include the development of new immunotherapies, advances in genomic profiling for personalized medicine, and the discovery of new biomarkers for early cancer detection. These advancements have led to FDA approvals of several new cancer treatments.
